| Company | Amount | Leerink Swann Role | Type | Date |
|---|---|---|---|---|
| Neurogen | $40 million | Co-Agent | Registered Direct | December 2006 |
| Arena | $175 million | Co-Manager | Follow-on Offering | December 2006 |
| MannKind | $400 million | Co-Manager | Follow-on Offering | December 2006 |
| Medivation | $36 million | Co-Agent | Registered Direct | December 2006 |
| Hansen Medical | $86 million | Co-Manager | IPO | November 2006 |
| CollaGenex | $45 million | Financial Advisor | Registered Direct | November 2006 |
| Celgene | $1 billion | Co-Manager | Follow-on Offering | November 2006 |
| Inverness Medical Innovations | $151 million | Co-Agent | PIPE | August 2006 |
| Osiris Therapeutics | $39 million | Co-Manager | IPO | August 2006 |
| Biodel | $21 million | Placement Agent | Private Placement | July 2006 |
| Indevus Pharmaceuticals | $35 million | Co-Manager | Follow-on Offering | June 2006 |
| BioProcessors | $18 million | Sole Placement Agent | Private Placement | June 2006 |
| Sima Therapeutics | $51 million | Co-Manager | Follow-on Offering | May 2006 |
| Northstar Neuroscience | $122 million | Co-Manager | IPO | May 2006 |